OBJECTIVE: To develop a method for the determination of Cytarabine (AraC) and its metabolite (uracil arabinoside, Ara-U) in plasma of AML patients.

• 目的：建立测定阿糖胞苷（Ara－C）及其代谢产物阿糖尿苷（Ara－U）血药浓度的方法，并用于5例急性髓细胞白血病（AML）患者血药浓度监测。